SANUWAVE Health, Inc. - 10-Q Filing
SANUWAVE Health filed a quarterly report (Form 10-Q) for the period ending March 31, 2026. The filing includes unaudited financial statements showing revenue from consumables, parts, accessories, system sales, extended warranties, and license fees. Total operating expenses include cost of goods sold ($489K), general & administrative costs ($575K), selling & marketing ($312K), and research & development ($603K). The company reported a net loss for the quarter but did not disclose specific revenue or EPS figures.
Tickers: $SNWV